MoldCo

MoldCo is revolutionizing healthcare by addressing the public health crisis of mold-related illnesses, an area often overlooked by traditional medicine. With our evidence-based, patented approach and founding team of world-leading scientists, pioneers and physicians, we are making specialized care accessible to patients suffering from Mold Toxicity / Chronic Inflammatory Response Syndrome (CIRS).

MoldCo has raised $11 million in funding and we are now expanding our services nationwide, offering the first-of-its-kind telehealth solutions, specialized lab tests, and evidence-backed treatments.